Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

internal dosimetry

  • You have access
    Modern Radiopharmaceutical Dosimetry Should Include Robust Biodistribution Reporting
    Adam L. Kesner and Lisa Bodei
    Journal of Nuclear Medicine October 1, 2018, 59 (10) 1507-1509; DOI: https://doi.org/10.2967/jnumed.118.208603
  • You have access
    Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody–Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
    Johan Blakkisrud, Jon Erik Holtedahl, Ayca Løndalen, Jostein Dahle, Tore Bach-Gansmo, Harald Holte, Stine Nygaard, Arne Kolstad and Caroline Stokke
    Journal of Nuclear Medicine April 1, 2018, 59 (4) 704-710; DOI: https://doi.org/10.2967/jnumed.117.195347
  • You have access
    Uncertainty Quantification in Internal Dose Calculations for Seven Selected Radiopharmaceuticals
    Vladimir Spielmann, Wei Bo Li, Maria Zankl, Uwe Oeh and Christoph Hoeschen
    Journal of Nuclear Medicine January 1, 2016, 57 (1) 122-128; DOI: https://doi.org/10.2967/jnumed.115.160713
  • You have access
    Biodistribution and Radiation Dosimetry of 18F-CP-18, a Potential Apoptosis Imaging Agent, as Determined from PET/CT Scans in Healthy Volunteers
    Mohan Doss, Hartmuth C. Kolb, Joseph C. Walsh, Vani Mocharla, Hong Fan, Ashok Chaudhary, Zhihong Zhu, R. Katherine Alpaugh, Miriam N. Lango and Jian Q. Yu
    Journal of Nuclear Medicine December 1, 2013, 54 (12) 2087-2092; DOI: https://doi.org/10.2967/jnumed.113.119800
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire